Assessing in vitro activity of oral third generation cephalosporin / beta-lactamase inhibitor combinations against extended spectrum beta-lactamase (ESBL) producing uropathogens (2020–2022)

Grant type:
The Royal College of Pathologists of Australasia
Researchers:
  • ATH - Lecturer
    Royal Brisbane Clinical Unit
    Faculty of Medicine
Funded by:
The Royal College of Pathologists of Australasia